Ampersand Biomedicines
Total Funding
$130 Million
Total Rounds
2
First Raise
Mar 19, 2025
Latest Raise
Mar 19, 2025
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
Showing 1 of 2 rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 3/19/2025 | Series B | $65 Million | Flagship Pioneering, Ampersand’s founder, Eli Lilly & Company |
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics